Welcome to the Investor Centre

Arix Bioscience plc (LSE: ARIX) is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors.

We are here for two reasons. One is to make a difference to patients’ lives. Second is to generate a return for our investors.

Highlights

£328m

NAV (at 31 Dec 2020)

242p

NAV per share (at 31 Dec 2020)

£174m

Capital pool (at 31 Dec 2020)

£158m

Cash realisations in 2020

LON:ARIX